Clinical trial
Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Locally Advanced Head and Neck Cancer
NCT02366611 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Locally Advanced Head and Neck Cancer
- Lead sponsor
- University of Michigan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- November 30, 2019
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of head and neck